Matthew C Dallos
Overview
Explore the profile of Matthew C Dallos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dallos M, Eisenberger A, Bates S
Oncologist
. 2020 Feb;
25(2):132-139.
PMID: 32043768
Venous thromboembolism (VTE) frequently occurs in patients with cancer, and particularly those with pancreatic ductal adenocarcinoma (PDAC). Therapeutic anticoagulation with either low-molecular-weight heparin or a direct oral anticoagulant is clearly...
12.
Hawley J, Pan S, Figg W, Lopez-Bujanda Z, Strope J, Aggen D, et al.
Prostate
. 2020 Jan;
80(4):336-344.
PMID: 31899823
Background: Immunosuppressive cytokines have the potential to promote prostate cancer progression. Assessing their longitudinal changes may implicate mechanisms of progression, treatment resistance, and suggest new therapeutic targets. Methods: Thirty-seven men...
13.
Comiskey M, Dallos M, Drake C
Curr Oncol Rep
. 2018 Aug;
20(9):75.
PMID: 30120592
Immunotherapy is rapidly transforming cancer care across a range of tumor types. Although Sipuleucel-T represented the first successful vaccine for the treatment of established cancer, other immunotherapeutic approaches for prostate...
14.
Dallos M, Drake C
Cancer J
. 2018 Jan;
24(1):20-30.
PMID: 29360724
Genitourinary malignancies represent a diverse biologic and immunologic landscape. Recently, checkpoint blockade has transformed the treatment paradigms for bladder and kidney cancer. However, continued progress will be essential in bladder...